Filings Intelligence
Company filings profile · CIK 0001788028

Jasper Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Jasper Therapeutics, Inc. (JSPR): 28 filings in the last 90 days vs 12 in the prior 90 (filing-velocity rising ↑ · 2.33×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 5, 2026. Source-linked, daily-refreshed.

Material 8-K events — Jasper Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 28, 2026Departure/Election of Directors or Officers↗
Aug 26, 2026Entry into a Material Agreement↗
Aug 14, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Aug 3, 2026Item 5.07↗
Jul 31, 2026Other Events↗
Jul 17, 2026Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits↗
Jul 16, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Jun 9, 2026Delisting / Listing-Rule Failure↗
Jun 1, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
May 21, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
May 14, 2026Results of Operations (earnings); Financial Statements and Exhibits↗

Watch Jasper Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
Aug 4, 20264↗
Aug 4, 20264↗
Aug 4, 20264↗
Aug 4, 20264↗
Aug 4, 20264↗
Jul 23, 20263↗
Jul 22, 20264↗
Jul 22, 20263↗
Jul 22, 20263↗
Jul 20, 20264↗
Jul 20, 20263↗
Feb 10, 20264↗
Jan 5, 20264↗
Jan 5, 20264↗
Jan 5, 20264↗

Recent filings

FiledFormDetail
Oct 5, 20268-K/A Financial Statements and Exhibits ↗
Oct 1, 20268-K/A Financial Statements and Exhibits ↗
Sep 28, 20268-K Departure/Election of Directors or Officers ↗
Sep 24, 202625-NSE ↗
Sep 4, 2026DEF 14A PROXY STATEMENT ↗
Aug 26, 20268-K Entry into a Material Agreement ↗
Aug 24, 2026PRE 14A PROXY STATEMENT ↗
Aug 17, 2026SCHEDULE 13G ↗
Aug 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Aug 14, 202610-Q QUARTERLY REPORT ↗
Aug 5, 2026D Item 06b ↗
Aug 4, 20264 ↗
Aug 4, 20264 ↗
Aug 4, 20264 ↗
Aug 4, 20264 ↗
Aug 4, 20264 ↗
Aug 3, 20268-K Item 5.07 ↗
Jul 31, 20268-K Other Events ↗
Jul 23, 20263 ↗
Jul 22, 20264 ↗
Jul 22, 20263 ↗
Jul 22, 20263 ↗
Jul 20, 20264 ↗
Jul 20, 20263 ↗
Jul 20, 2026SCHEDULE 13D/A ↗
Jul 17, 20268-K Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jul 16, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jul 10, 2026SCHEDULE 13G/A ↗
Jun 15, 2026ARS ARS ↗
Jun 15, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS ↗
Jun 15, 2026DEF 14A PROXY STATEMENT ↗
Jun 9, 20268-K Delisting / Listing-Rule Failure ↗
Jun 1, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
May 21, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
May 14, 202610-Q QUARTERLY REPORT ↗
May 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
May 12, 2026SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A ↗
Apr 30, 202610-K/A AMENDMENT NO. 1 TO FORM 10-K ↗